Use of imatinib mesylate in elderly patients in Northern Ireland: evidence of comparable haematological and molecular responses to younger patients.

Autoria(s): Sheehy, O.M.; Irvine, Alexandra; Cuthbert, Robert; Humphreys, M.W.; McMullin, Mary
Data(s)

01/06/2008
Identificador

http://pure.qub.ac.uk/portal/en/publications/use-of-imatinib-mesylate-in-elderly-patients-in-northern-ireland-evidence-of-comparable-haematological-and-molecular-responses-to-younger-patients(462f2636-ef71-44f9-b715-512cdac0ae0f).html

http://dx.doi.org/10.1179/102453308X316004

http://www.scopus.com/inward/record.url?scp=55849109626&partnerID=8YFLogxK
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Sheehy , O M , Irvine , A , Cuthbert , R , Humphreys , M W & McMullin , M 2008 , ' Use of imatinib mesylate in elderly patients in Northern Ireland: evidence of comparable haematological and molecular responses to younger patients. ' Hematology (Amsterdam, Netherlands) , vol 13(3) , no. 3 , pp. 133-136 . DOI: 10.1179/102453308X316004
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2720 #Hematology
Tipo

article
Acesso ao item digital